Skip to content

Prevention of Cervical Cancer (PRECERCA 1)

Prevention of Cervical Cancer (PRECERCA 1) : Implementing point of care HPV testing strategy for cervical cancer screening among tea garden workers in North Bengal : A pilot project. - PRECERCA

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/10/046796
Enrollment
1000
Registered
2022-10-26
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Cervical cancer Screening: Point of care cervical cancer screening and Awareness Control Intervention1: Nil: Nil

Sponsors

Cepheid India
Lead Sponsor
Manisha Nandi Foundation
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Women between 30 to 60yrs willing to participate in the study.

Exclusion criteria

Exclusion criteria: 1. Known case of cervical cancer /on treatment/completed treatment / on follow up.2.Pregnancy

Design outcomes

Secondary

MeasureTime frame
Evaluation of success of awareness and implementation by using the REAIM framework (feasibility, acceptability, satisfaction, barriers, validity, scalability) and CAM (cancer awareness method) toolkit. Economic analysis- cost benefit analysis/effectiveness, willingness to pay).Qualitative studies in a subset of KAP (knowledge, attitude, practice) and preference.Biospecimen collection- for parallel HPV testing/ microbiome/ biobanking. Comparison with other geographical areas (remote) tested using the conventional 2-3 stage methodology using other HPV tests. Future grant applications based on pilot data and larger scale studies in other remote regionsTimepoint: 1 yr

Primary

MeasureTime frame
ï?§Success of implementation - EASE (Ethical Easy Acceptable Affordable Sustainable Scalable Effective Early diagnosis and treatment) (matrix/ score) ï?§Improvement in KAP in population/provider/community for cancer prevention ï?§Effect on cancer burden Timepoint: baseline and 1 year

Countries

India

Contacts

Public ContactDr Sreeya Bose

Chittaranjan National Cancer Institute

manu_1486@yahoo.co.in9051239019

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026